Josh Muntner joins Mesoblast as CFOJosh Muntner has been appointed Chief Financial Officer of Mesoblast. He will be based in New York. more ➔
PureTechs Gelesis Appoints Harry Leider...PureTech Health plc announced today that its affiliate, Gelesis, has appointed Harry Leider, MD, MBA, former Chief Medical Officer and Group Vice President of Walgreens, as Chief Medical Officer. more ➔
Hikma appoints Henriette NielsenHikma Pharmaceuticals PLC announces the appointment of Henriette Nielsen to the newly created role of Chief Transformation Officer. more ➔
Sygnature Discovery appoints Dr Bill Marat...Sygnature Discovery, thas appointed Dr Bill Marathias as Vice President of Business Development for the US to assist with the companys international growth plans. more ➔
Bavarian Nordic to appoint Henrik Juuel as...Bavarian Nordic A/S today announced the appointment of Henrik Juuel to the position of Executive Vice President and Chief Financial Officer. Mr. Juuel is currently the CFO of Orexo AB. more ➔
Rainer Boehm joins Nordic Nanovector Board...Nordic Nanovector ASA today announces that Rainer Boehm, MD was elected as a member of its Board of Directors at the companys Annual General Meeting on 30 May 2018. more ➔
Nouscom Appoints Adrian Woolfson as CMONouscom, an immuno-oncology company developing off-the-shelf and personalized neoantigen-based genetic cancer vaccines, announced today the appointment of Adrian Woolfson M.D., Ph.D. as Chief Medical … more ➔
Aldevron Names Marc Wolff CFOMarc Wolff has been named Chief Financial Officer of Aldevron, a provider of plasmid DNA manufacturing, protein production and antibody discovery services. Mr. Wolff will lead the global finance and … more ➔
Horizon Discovery appoints Terry Pizzie as...Horizon Discovery Group plc has announced the appointment of Terry Pizzie as Chief Executive Officer and Board Director with immediate effect. more ➔
Bayer announces new Crop Science Leadershi...Bayer today announced the selection of the new Executive Leadership Team for the Crop Science division, which will go into effect as of the closing of Bayers proposed acquisition of Monsanto. The closing … more ➔